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Abstract: Extracorporeal membrane oxygenation (ECMO) is increasingly being used to treat severe acute respira-
tory distress syndrome (ARDS). However, there is limited clinical evidence about how to optimize the technique. 
Experimental research can provide an alternative to fill the actual knowledge gap. The purpose of the present study 
was to develop and validate an animal model of acute lung injury (ALI) which resembled severe ARDS, and which 
could be successfully supported with ECMO. Eighteen pigs were randomly allocated into three groups: sham, ALI, 
and ALI + ECMO. ALI was induced by a double-hit consisting in repeated saline lavage followed by a 2-hour period 
of injurious ventilation. All animals were followed up to 24 hours while being ventilated with conventional ventilation 
(tidal volume 10 ml/kg). The lung injury model resulted in severe hypoxemia, increased airway pressures, pulmo-
nary hypertension, and altered alveolar membrane barrier function, as indicated by an increased protein concen-
tration in bronchoalveolar fluid, and increased wet/dry lung weight ratio. Histologic examination revealed severe 
diffuse alveolar damage, characteristic of ARDS. Veno-venous ECMO was started at the end of lung injury induction 
with a flow > 60 ml/kg/min resulting in rapid reversal of hypoxemia and pulmonary hypertension. Mortality was 0, 
66.6 and 16.6% in the SHAM, ALI and ALI + ECMO groups, respectively (p < 0.05). This is a novel clinically relevant 
animal model that can be used to optimize the approach to ECMO and foster translational research in extracorpor-
eal lung support. 
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Introduction
Despite the increasing use of extracorporeal 
membrane oxygenation (ECMO) in acute res-
piratory distress syndrome (ARDS), there is 
quite low evidence about its efficacy or how to 
optimize its application [1, 2]. Although the 
number of patients receiving ECMO is increas-
ing steadily worldwide [3], it is still difficult 
to perform controlled studies in these patients. 
At this stage, the few published large clinical 
trials have been focused on trying to demon-
strate the general efficacy of ECMO to improve 
survival [4]. However, other relevant aspects of 
care such as mechanical ventilation, during 
ECMO, or the introduction of technological 
innovations in extracorporeal circulation, have 
not been well studied and current practices 
are widely variable and based mainly on un- 
controlled studies or on general recommenda-
tions [5-7]. Animal models and translational 
research can provide an alternative to explore 
the optimal care and novel interventions during 
ECMO. 
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A few animal studies with ECMO have been 
published during the last years exploring physi-
ologic consequences of ECMO on coagulation, 
pharmacokinetics or organ function [8-11]. 
Some of these studies have used acute lung 
injury models. However, the reported models 
do not appear well suited or relevant to study 
optimal approaches to care during ECMO. Major 
limitations of current models are doubtful clini-
cal relevance concerning severe ARDS, insuffi-
cient duration of the models to detect more 
subtle modifications, or insufficient severity 
compared to ARDS patients treated with ECMO 
[10, 12].
The goal of the present study was to develop 
and characterize a large animal model of acute 
lung injury which resembled clinical severe 
ARDS, refractory to conventional mechanical 
ventilation, and which could be supported suc-
cessfully with high flow veno-venous ECMO 
(vvECMO) for at least 24 hours. 
Materials and methods
This study was conducted with the approval of 
the Pontificia Universidad Católica de Chile 
Animal Ethics Committee, approval number 
12-029. All experiments were performed in 
accordance to the Guide for the Care and Use 
of Laboratory Animals, 8th Edition, from the 
National Academy of Sciences of the United 
States of America.
Animal preparation 
Eighteen pigs (Sus scrofa domestica) (30±5 kg) 
were used in the study. Animals were housed 
at the research facility the day before, fasted 
for 12 hours before experiments, with water 
access ad libitum. Animals were pre medicated 
with ketamine (20 mg·kg-1) + xylazine (2 mg·kg-1) 
+ Atropine (0.05 mg·kg-1) intramuscularly. Once 
sedated, a catheter was placed in the marginal 
ear vein, and anesthesia induced with a combi-
nation of fentanyl (30 µg·kg-1), midazolam (0.25 
mg·kg-1) and atracurium (0.5 mg·kg-1) intrave-
nously. Pigs were then intubated with an endo-
tracheal tube (6.0-7.0 ID), and connected to a 
mechanical ventilator in volume controlled ven-
tilation (VCV) mode (Dräger Evita XL®, Lübeck, 
Germany). Initial ventilatory settings included 
positive end-expiratory pressure (PEEP) of 5 
cmH2O, tidal volume (Vt) 10 ml·kg
-1, and an I:E 
ratio 1:2. Respiratory rate (RR) was initially set 
at 16-18·min-1, and adjusted thereafter to keep 
PaCO2 between 30-50 mmHg. Inspired oxygen 
fraction (FiO2) was kept at 1.0 throughout all 
the experiment. Anesthesia was maintained 
with a continuous intravenous infusion of a 
solution consisting of midazolam 2 mg·ml-1, fen-
tanyl 20 μg·ml-1, and ketamine 20 mg·ml-1, set 
at 0.5 ml·kg-1·h-1 during invasive procedures and 
induction of lung injury, and at 0.25 ml·kg-1·h-1 
thereafter until the end of the experiment. 
Depth of anesthesia was assessed regularly by 
checking for movements or hemodynamic 
response to a painful stimulus. Muscle paraly-
sis was maintained with a continuous infusion 
of atracurium (0.5 mg·kg-1·h-1) throughout the 
experiment. At the time of instrumentation, 30 
mg·kg-1 of cephazolin was administered intrave-
nously and repeated every 8-hours thereafter. 
Animals received normal saline at 10 ml·kg-1·h-1 
during preparation and while inducing lung inju-
ry, and 2 ml·kg-1·h-1 during the 24-hour study 
period.  The body temperature of the animals 
was kept at 38±1°C. 
Under sterile conditions, the left carotid artery 
and left external jugular vein were surgically 
exposed for insertion of arterial and pulmonary 
artery catheters, respectively. A pulmonary 
artery catheter was placed under direct pres-
sure curve guidance. A percutaneous cystosto-
my was placed to measure urine output. After 
completing instrumentation, baseline data was 
collected. Electrocardiogram, arterial blood 
pressure, pulmonary artery pressure, cardiac 
output, heart rate, pulse oximetry, and core 
temperature were monitored periodically. 
Induction of lung injury
A 2-hit model of ARDS was applied, starting 
with lung lavages to deplete the lungs of alveo-
lar surfactant, followed by injurious mechanical 
ventilation. With animals under deep anesthe-
sia and fully monitored, we performed repeated 
lung lavages with warm saline (30 ml·kg-1, 
39°C), alternating 2 in supine and 2 in prone 
position. The setting of mechanical ventilation 
between lavages was the same as that 
described above. Subsequent lavages were 
performed if necessary until PaO2 felt below 
250 mmHg for at least 15 minutes while in 
supine position. Subsequently, a two-hour peri-
od of injurious ventilation was started in pres-
sure control ventilation, with PEEP 0 cmH2O 
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and inspiratory pressure of 40 cmH2O, at a 
respiratory rate of 10·min-1, I:E of 1:1, and FiO2 
1.0. The first hour was in prone position and the 
second in supine position. After completing this 
two-hour period, ventilator settings were 
returned back to those used at baseline for 10 
minutes and a full assessment of all variables 
was registered (time 0-T0), before starting the 
24-hour study period.
Extracorporeal membrane oxygenation (ECMO) 
setup 
The ECMO equipment included a magnetic 
Medtronic Bio-Medicus® 540 centrifuged 
pump (Eden Praire, MN, USA), a coagulation 
monitor (Hemochron® Response, ITC, USA), 
and a heat exchanger HU-35 (Maquet, USA). 
The circuit comprised a HILITE® 2400LT poly-
methylpentene hollow fiber membrane oxygen-
ator, 0.65 m2 (MEDOS, Stolberg, Germany), 
polyvinyl chloride ¼-inch lines coated with 
rheoparin, and a Rotaflow 32 head pump 
(Maquet, USA). The circuit was primed with 
saline. Pressure transducers were placed 
before and after the membrane, and a negative 
pressure transducer was connected to the 
drainage line.
In animals allocated to ECMO, cannulation was 
performed during the second hour of injurious 
ventilation, while pigs were in supine position. 
Under sterile conditions, the right external jugu-
lar vein was surgically exposed and a 23-F bi-
caval dual lumen (BCDL) catheter (AVALON 
ELITE®, Maquet, USA) was inserted and direct-
ed towards the inferior vena cava, and secured 
at 18 cm from the tip. In pilot experiments we 
observed that the infusion port consistently 
remained facing the right atrium at this depth. 
Anticoagulation was induced with an intrave-
nous heparin bolus (100 IU·kg-1), followed by a 
continuous infusion targeting an activated clot-
ting time (ACT) of 180-220 s. The BCDL cathe-
ter was connected to the circuit after T0 mea-
surements and extracorporeal circulation start-
ed progressively. The pump was adjusted to 
target a blood flow > 65 ml/kg/min, but keep-
ing pressure in the drainage line above -70 
mmHg. Heat exchanger was set at 38°C. The 
initial sweep gas flow (FiO2 1.0) was set at 1:1 
with blood flow, and then titrated to keep an 
arterial PaCO2 between 40±10 mmHg. In pilot 
experiments we observed that hypotension 
was frequent after connection to ECMO, and 
that moderate doses of noradrenaline were 
required despite adequate fluid loading. 
Therefore, our protocol established that a 
noradrenaline infusion was started promp- 
tly after connection to ECMO in case mean arte-
rial pressure felt below 65 mmHg. If hypoten-
sion persisted despite noradrenaline (0.1 
mcg·kg-1·min-1), or if pulse pressure variation 
was > 15%, animals received a fluid challenge 
with normal saline 2 ml·kg-1. Further fluid chal-
lenges were decided according to fluid and 
vasopressor responsiveness.
Study protocol
After instrumentation and baseline measure-
ments, 18 animals were randomly allocated to 
one of the three following study groups: 
Sham: animals were ventilated with the same 
parameters as baseline for 3 hours (to parallel 
the time spent in inducing lung injury in the 
other groups), but without inducing lung injury. 
Thereafter, the 24-hour study period was start-
ed with conventional mechanical ventilation: 
VCV, Vt 10 ml·kg-1, PEEP 5 cmH2O, RR adjusted 
to PaCO2 30-50 mmHg, I:E ratio 1:2 (n = 6). 
Acute lung injury (ALI): lung injury was induced 
as described above, followed by the 24-hour 
study period with conventional mechanical ven-
tilation: VCV, Vt 10 ml·kg-1, PEEP 5 cmH2O, RR 
adjusted to PaCO2 30-50 mmHg, I:E ratio 1:2 
(n = 6).  
Acute lung injury + ECMO (ALI + ECMO): lung 
injury was induced as described above, but per-
forming cannulation during the second hour of 
injurious ventilation. Thereafter, ECMO was 
started at T0, along with conventional mechani-
cal ventilation for the 24-hour study period: 
VCV, Vt 10 ml·kg-1, PEEP 5 cmH2O, RR as set at 
baseline, I:E ratio 1:2 (n = 6).  
Monitoring, sampling and measurements
Heart rate, pulse oximetry, core temperature, 
arterial blood pressure, pulmonary artery pres-
sure, respiratory rate and respiratory mechan-
ics, ventilator and ECMO settings, anesthetic 
drugs and maintenance fluids, as well as infu-
sion drugs for hemodynamic support were 
recorded and registered hourly for the 24-hour 
study period. 
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Blood was drawn for blood gas and biochemical 
analysis at baseline, T0, T3, T12 and T24. Non-
bronchoscopic bronchoalveolar lavages (BAL) 
with 0.5 ml·kg-1 of warm saline were performed 
at T0, T3 and T24. Plasma and cell-free BAL 
fluid (BALF) samples were obtained by centrifu-
gation and immediately frozen and kept at 
-80°C for further analysis. Changes in BALF 
total protein content were determined as a sur-
rogate of alveolar-capillary membrane permea-
bility. Total protein content in BALF was mea-
sured using the Bradford method [13]. Plasma 
and BALF urea concentrations were determined 
in order to account for the dilution of BALF sam-
ples. Epithelial lining fluid 
(ELF) protein concentra-
tions were calculated 
using the following equa-
tion: [protein in ELF] = 
([protein in BALF] x [plas-
ma urea])/[BALF urea] 
[14].
At the end of the 24-hour 
study period, animals 
were euthanized by an 
overdose of thiopental 
and T-61 euthanasia so- 
lution (Intervet Interna- 
tional B.V, Netherlands). 
Immediately after eutha-
nasia, a thoracotomy was 
performed in order to 
access the lungs. Lungs 
were kept inflated at an 
end inspiratory pressure 
of 20 cmH20 by clamping 
the endotracheal tube. 
The left bronchus was 
tightly sutured in order to 
separate the left from the 
right lung. Samples were 
obtained from the depen-
dent and non-dependent 
regions of the left superi-
or, middle and inferior 
lobes, for total lung water 
estimation [15]. Briefly, all 
sections were weighted 
immediately upon extrac-
tion and then dried for 24 
hours at 120°C. After 
weighting the dry portions 
of the lungs, a wet-dry-
weight ratio was obtained 
Table 1. Hemodynamic variables
Variable SHAM ALI ALI + ECMO
HR (·min-1)   
    Baseline 96 [78, 131]# 91 [68, 106] 69 [50, 92]
    T0 76 [69, 92] 117 [92, 152] 81 [60, 121]
    T3 60 [52, 88] 145 [120, 204]* 137 [110, 159]*,#
    T12 74 [57, 145] 123 [107, 139] 114 [90, 130]
    T24 77 [64, 113] 98 [91, 104] 108 [77, 121]
MAP (mmHg)   
    Baseline 90 [80.5, 104] 99 [85, 141] 102 [75, 105]
    T0 103 [91, 109] 90 [87, 106] 81 [66, 116]
    T3 94 [85, 103] 98 [86, 124] 70 [59, 82]#
    T12 82 [70, 100] 93 [89, 96] 71 [62, 81]#
    T24 71 [64, 81]# 64 [58, 69] 67 [61, 93]#
CO (L·min-1)   
    Baseline 2.5 [2.2, 2.9] 2.9 [2.6, 3.2] 3.1 [2.9, 3.3]  
    T0 2.5 [2.2, 2.9] 3.5 [3.3, 4.3] 2.7 [2.7, 3.8]
    T3 2.7 [2.3, 3.1] 4.3 [3.7, 4.8] NM
    T12 3.2 [2.1, 3.8] 3.8 [3.7, 3.8] NM
    T24 2.4 [2.0, 2.8] 3.6 [3.6, 3.6] NM
mPAP (mmHg)   
    Baseline 17 [17, 24] 15 [14, 18]# 21 [18, 23]#
    T0 21 [19, 24] 39 [33, 40]* 38 [37, 40]*
    T3 22 [18, 23] 34 [31, 36]* 29 [23, 31]#
    T12 24 [17, 26] 24 [20, 28] 19 [18, 20]#
    T24 23 [16, 24] 21 [20, 21] 17 [14, 18]
NA (ug·kg-1·min-1)   
    Baseline 0.00 [0.00, 0.00] 0.00 [0.00, 0.00] 0.00 [0.00, 0.00]
    T0 0.00 [0.00, 0.00] 0.00 [0.00, 0.00] 0.01 [0.00, 0.04]
    T3 0.00 [0.00, 0.00] 0.00 [0.00, 0.00] 0.12 [0.10, 0.15]#,*,£
    T12 0.00 [0.00, 0.00] 0.00 [0.00, 0.00] 0.14 [0.10, 0.14]#,*,£
    T24 0.00 [0.00, 0.00]  0.00 [0.00, 0.00] 0.23 [0.16, 0.33]#,*,£
All results show median [percentile 25, 75] except for ALI group at T12, T24 
(median[range]). #p < 0.05 compared to T0; *p < 0.05 compared to SHAM; £p < 0.05 
compared to ALI. HR, Heart rate; MAP, mean arterial pressure; CO, Cardiac output; 
mPAP, mean pulmonary arterial pressure; NA, Noradrenaline; NM, not measured.
and reported as an average of all sections. The 
right lung was filled with formaldehyde at 20 
cmH2O. 
Lung tissue histology 
Tissue samples from the dependent region of 
the right middle lung lobe were kept in cold 
formaldehyde for 24 hours and then embedded 
in paraffin for microscopic assessment of acute 
lung injury markers according to a recommend-
ed score ranging from 0 (healthy) to 1 (maximal 
injury), which includes alveolar wall thickening 
and the presence of inflammatory cells, pro-
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teinaceous debris, and 
hyaline membranes in the 
alveolar space [15]. 
Statistical analysis
All data are presented as 
median [percentile 25, 
75]. Comparison between 
groups was performed by 
Kruskal Wallis test, fol-
lowed by Bonferroni post 
hoc test. Since several ani-
mals of group ALI died 
before completing the 
study period, we analyzed 
changes along time by 
comparing all time points 
versus T0 using Wilcoxon 
signed-rank test, instead 
of performing a multiple 
comparison analysis. Sur- 
vival analysis was per-
formed by Log-rank test 
(Mantel-Cox). A P-value < 
0.05 was considered to be 
statistically significant. All 
analyses were performed 
using Statistical Package 
for Social Science (SPSS) 
Statistics 20.0.
Results
Characteristics of the 
acute lung injury model
Induction of acute lung 
injury required 8 [7, 9] lava- 
ges to reach a PaO2/FiO2 
< 250. After the 2-hour 
period of injurious ventila-
tion, animals developed 
severe hypoxemia, increas- 
ed airway pressures and 
moderate pulmonary hy- 
pertension (Tables 1 and 
2). Due to persistent 
hypoxemia 4 of 6 animals 
died in the ALI group 
before completing the 
study period (Figure 1). 
The 2 animals that sur-
vived evolved with tachy-
cardia and increased car-
Table 2. Respiratory variables
Variable SHAM ALI ALI + ECMO
PaO2 (mmHg)   
    Baseline 331 [314, 414] 383 [360, 424]# 333 [276, 437]#
    T0 365 [331, 437] 35.5 [32.8, 40.3]* 47.0 [35.0, 125]*
    T3 352 [310, 392] 46.5 [38.3, 53.3]* 98.0 [75.8, 198]#
    T12 390 [348, 452] 73.5 [44.0, 103]* 182 [94.0, 321]#
    T24 314 [200, 426] 107 [80.0, 133] 255 [111, 314]#
PaCO2 (mmHg)   
    Baseline 35.9 [33.6, 40.9] 44.6 [42.6, 57.1] 36.8 [34.4, 45.7]
    T0 35.9 [32.8, 40.7] 49.9 [46.0, 59.8]* 33.7 [31.1, 45.3]£
    T3 42.6 [38.3, 43.8]# 64.1 [57.2, 70.1] 33.0 [29.1, 36.1]£
    T12 43.2 [38.9, 49.6] 52.2 [38.9, 65.5] 33.7 [29.2, 34.5]*,£
    T24 34.6 [31.4, 46.7] 48.0 [42.4, 53.1] 34.7 [28.5, 39.4]
SatO2 (mmHg)   
    Baseline 100 [100, 100] 100 [100, 100]# 100 [100, 100]#
    T0 100 [100, 100] 62 [55, 70]* 89 [62, 99]*
    T3 100 [100, 100] 74 [62, 83]* 97 [94, 100]£,#
    T12 100 [100, 100] 91 [84, 97]* 99 [98, 100]
    T24 100 [100, 100] 98 [96, 99] 99 [97, 100]
MV (L·min-1)   
    Baseline 5.2 [4.6, 7.8] 4.8 [4.5, 5.3]# 6.1 [5.2, 6.5]
    T0 5.1 [4.8, 7.3] 5.5 [5.3, 6.4] 6.7 [5.8, 8.8]
    T3 5.1 [4.9, 7.2] 5.9 [5.2, 8.3] 5.8 [4.6, 7.0]#
    T12 6.3 [5.6, 7.7] 7.4 [6.7, 8.1] 5.9 [4.9, 6.7]
    T24 6.8 [5.1, 7.9] 7.4 [6.7, 8.1] 6.6 [6.2, 7.4]
Pplat (cmH2O)   
    Baseline 13 [13, 16] 12 [12, 15]# 14 [13, 16]#
    T0 15 [14, 17] 25 [22, 27]* 28 [22, 33]*
    T3 15 [13, 18] 26 [25, 27]* 30 [27, 33]*
    T12 16 [14, 18] 22 [20, 24] 31 [25, 31]*
    T24 16 [13, 18] 27 [23, 30]* 28 [23, 30]*
Ppeak (cmH2O)   
    Baseline 20 [18, 24] 17 [16, 18]# 17 [16, 19]#
    T0 20 [15, 22] 30 [29, 31]* 38 [31, 43]*
    T3 22 [17, 23]# 31 [31, 33]* 34 [30, 41]*
    T12 23 [20, 24]# 33 [30, 35]* 32 [29, 35]*
    T24 23 [20, 25]# 35 [32, 39]* 34 [27, 35]*
Pmean (cmH2O)   
    Baseline 9 [8, 10] 8 [7, 8]*,# 8 [8, 8]*,#
    T0 9 [8, 9] 11 [11, 13]* 15 [13, 15]*
    T3 8 [8, 9] 12 [12, 14]* 11 [10, 14]*
    T12 9 [8, 10] 11 [10, 11] 12 [11, 20]*
    T24 9 [8, 11] 12 [11, 12] 12 [11, 16]
All results show median [percentile 25, 75] except for ALI group at T12, T24 (median 
[range]). #p < 0.05 compared to T0; *p < 0.05 compared to SHAM; £p < 0.05 compared 
to ALI. MV, minute ventilation; Pplat, plateau pressure; Ppeak, peak pressure; Pmean, 
mean airway pressure.
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diac output during the first hours but their oxy-
genation slowly improved regaining a PaO2 > 60 
mmHg by the end of the study period. In con-
trast, airway pressures remained high until the 
end of the experiment. Protein concentration in 
the ELF was markedly increased in both ALI and 
ALI + ECMO groups, and remained high through-
out the study period (Figure 3A).
Only 2 animals from the ALI group and 5 from 
the ALI + ECMO group completed the study 
period and had lung tissue samples retrieved 
for analysis. Pulmonary wet/dry weight ratios 
were increased, indicating significant lung 
edema in all the animals subjected to ALI 
(Figure 3B). Histology revealed a severe pat-
tern of diffuse alveolar damage, the pathologic 
hallmark of ARDS, with presence of hyaline 
membranes, alveolar wall thickening and exten-
sive infiltration with inflammatory cells, as 
shown in Figure 2. 
Concerning biochemical data, induction of ALI 
was associated to a non-significant trend 
towards increased lactate at T0, and increased 
serum glutamic oxaloacetic transaminase at 
T12 and T24.
Performance of extracorporeal membrane 
oxygenation 
Cannulation could be performed successfully 
in all animals. Connection to ECMO was fol-
lowed by rapid reversal of hypoxemia and pul-
monary hypertension (Tables 1 and 2). However, 
hemodynamic instability was common during 
the first hour, with variable degrees of hypoten-
sion, which exhibited no response to fluids and 
therefore required moderate doses of noradren-
aline. Thereafter, most animals regained hemo-
dynamic stability, but remained dependent on 
noradrenaline until the end of the study period. 
One animal evolved with progressive hypoten-
sion non-responsive to vasopressor and fluids, 
and died before T2 (Figure 1). The other five 
animals completed the study period. Total fluid 
loading was 2472 ml [2188, 2933], 3532 ml 
[3470, 3549], and 3015 ml [2683, 3234], in 
the SHAM, ALI and ALI + ECMO groups, respec-
tively (p < 0.05 for SHAM vs ALI). Urine output 
was 1500 ml [945,2225], 2495 ml [2100, 
2890], 1405 ml [888, 1566], in the SHAM, ALI 
and ALI + ECMO groups, respectively (no signifi-
cant differences). When analysing biochemistry 
data in the ECMO group the only relevant obser-
vation was a trend towards increased creati-
nine concentrations, with no other side effects 
(Table 3). Oxygenation continued to improve 
throughout the 24-hour study period. At T24 
PaO2 was 255 mmHg [111, 314] while mixed 
venous PO2 was 77 mmHg [56, 100]. However, 
airway pressures remained high up to the end 
of the experiment indicating that lung compli-
ance did not improve. 
Extracorporeal blood flow reached 2.1 L·min-1 
[2.0, 2.2] at T1, which corresponded to 68.1 % 
[66.3, 69.4] of the last cardiac output meas-
ured at T0, just before starting ECMO. The 
pump speed was 2970 rpm [2305, 3000], with 
pressure in the drain line at -60 mmHg [-71, 
-43]. Pre and post membrane pressures were 
160 mmHg [97, 171] and 136 mmHg [82, 148], 
while pre and post membrane partial pressures 
of oxygen were 37 mmHg [36.8, 37.8] and 
143.5 mmHg [121, 183.8], respectively. As 
ventilator settings were not modified in the ALI 
+ ECMO group after starting ECMO, sweep gas 
flow had to be decreased to 0.7 L·min-1 [0.5, 
1.3] to avoid hypocapnia. However, in 2 sepa-
rate pilot experiments not included in the pre-
sent analysis, near-apneic ventilation (minute 
ventilation < 1 L·min-1) was applied during the 
24-hour study period. By increasing sweep gas 
flow, PaO2 and PaCO2 could be kept at rather 
normal levels (Supplementary Figure 1).
Discussion
We have developed a reproducible porcine 
24-hour model of severe acute respiratory fail-
ure supported with ECMO, which resembles 
Figure 1. Survival curves. Survival curves obtained 
from SHAM, ALI and ALI + ECMO groups, with six ani-
mals per group. Statistical analysis was performed 
by Log-rank test. *p < 0.05 compared to SHAM. 
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several features of clinical severe ARDS. Acute 
lung injury was induced by repeated saline lav-
age, followed by a 2-hour period of injurious 
mechanical ventilation, with both hits applied 
alternating supine and prone position to pro-
mote a more diffuse injury. The model is char-
acterized by severe hypoxemia refractory to 
mechanical ventilation with PEEP 5 cmH2O and 
FiO2 1.0, exhibiting a high lethality when not 
supported with ECMO. A high flow vvECMO 
could be provided with minimal recirculation, 
rapidly correcting hypoxemia and improving 
survival. 
Our goal was to develop a model of ARDS char-
acterized histologically by diffuse alveolar dam-
age, and functionally by severe hypoxemia and 
decreased compliance, to reproduce the con-
text in which ECMO is applied clinically, but 
without significant hemodynamic instability, so 
that vvECMO could be well tolerated. A few 
models of ALI supported with ECMO have been 
reported, including surfactant depletion [12, 
16], endotoxin [17], oleic acid infusion [18], 
and smoke inhalation [10], among others. 
Concerning optimal species, sheep and pigs 
are the preferred options. Although sheep offer 
advantages in terms of an easier cannulation, 
pigs have some physiologic advantages for 
translation to humans concerning coagulation 
[19]. It is clear that all animal models have sig-
nificant limitations and the optimal choice will 
depend on the particular goals and the research 
context.  
Figure 2. Histologic evaluation of lung sections. Representative histologic examinations of lung samples obtained 
from the dependent region of the right middle lobe of animals from the SHAM (A), ALI (B) and ALI + ECMO (C) groups. 
A normal lung architecture is observed in (A), whereas diffuse alveolar damage, as represented by the presence 
of inflammatory cells, both in the interstitial and alveolar space, capillary congestion, alveolar flooding, and the 
presence of hyaline membranes, are observed in (B and C). Lung injury was quantified by a validated score which 
includes alveolar wall thickening, the presence of inflammatory cells, proteinaceous debris, and hyaline membranes 
in the alveolar space, with a range from 0 to 1 [15] (D). Data corresponds to median [percentile 25, 75]. *p < 0.05 
compared to SHAM.
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After some preliminary experiments and ana-
lysing the published data we decided that sur-
factant depletion was the best option for our 
goal. However, lung inflammation is usually low 
in surfactant depletion models. Therefore we 
decided to add a second hit: injurious ventila-
tion. With this double hit model significant lung 
inflammation has been described [20]. In pilot 
experiments we observed that this model led to 
marked diffuse alveolar damage and severe 
hypoxemia, however, injury had an excessive 
gravitational distribution, and hypoxemia was 
easily reversible even with low PEEP levels. For 
this reason we decided to perform the double 
hit injury alternating supine and prone position, 
so that dorsal and ventral regions were equally 
affected, and promoting a more widespread 
development of atelectasis. This approach 
resulted in severe hypoxemia and a high mor-
tality as observed in the ALI group. In contrast, 
hypoxemia was rapidly corrected in the ALI + 
ECMO group, and 5/6 animals could complete 
the 24-hour study period. Furthermore, at the 
end of the 24-hour study period animals were 
in good condition and the model could have 
easily been extended. Interestingly, although 
gas exchange in the native lungs had partially 
recovered, as reflected by the large difference 
between PaO2 and mixed venous PO2 at T24, 
compliance remained low. We speculate that 
improvement in oxygenation may have not been 
due to reopening of atelectatic lung, but instead 
to a better ventilation-perfusion relationship. 
Since one of our goals was to develop a model 
of ECMO, with the ability to provide full lung 
support if necessary, one of the major challeng-
es was cannulation. Cervical veins in the pig 
are rather small compared to other species, 
while femoral veins are difficult to cannulate 
because of their deep location. The largest vein 
is the jugular external vein, which measures 5 
to 8 mm diameter for 30 kg pigs. We aimed to 
have a high blood flow extracorporeal setting 
with low recirculation, so that full support could 
be provided. Therefore we decided to use a 
BCDL catheter. After trying different sizes we 
found that the largest cannula we could place 
was a 23 French. In the first experiments we 
used transthoracic ultrasound to make sure 
that the cannula was directed towards the infe-
rior vena cava and not into the right ventricle. 
However, thereafter we were able to introduce 
it correctly without ultrasound, just by advanc-
ing blindly the wire guide at least 40 cm without 
observing arrhythmias. The cannula was 
advanced with the introducer over the wire 
guide and secured at 18 cm from the tip. In 
post mortem analysis we observed that by 
using this approach the cannulas were correct-
ly placed towards the inferior vena cava and the 
return port remained at the right atrium level in 
Figure 3. Surrogates of alveolar membrane barrier integrity (A). Epithelial lining fluid protein concentration calculat-
ed from non-bronchoscopic bronchoalveolar lavage samples, with correction for dilution by Urea (B). Wet/dry weight 
ratio obtained from the left lungs of the three study groups (A, B). Data corresponds to median [percentile 25, 75]. 
*p < 0.05 compared to SHAM. ELF (Epithelial lining fluid). 
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all cases. Although we 
could not perform reliable 
calculations of recircula-
tion, because of the 
impossibility of obtaining 
representative pure ve- 
nous blood samples from 
the vena cava, the very 
low pre-membrane PO2 
indicates that recircula-
tion was probably very low 
[21].
In the present study we 
did not modify ventilator 
settings after connecting 
the animals to ECMO, as 
usually done in the clinical 
scenario, because our 
goal at this stage was to 
assess the isolated effect 
of extracorporeal circula-
tion and gas exchange in 
our ALI model, without 
the additional influence 
of protective ventilation. 
However, in two separate 
pilot experiments we were 
able to induce near-apneic 
ventilation keeping nor-
mal arterial blood gases, 
as shown in Supple- 
mentary Figure 1, indicat-
ing that the ECMO setting 
applied is able to provide 
full lung support. In fact, 
the following studies will 
compare different strate-
gies of lung protection 
during ECMO in this 
model. In addition, we 
decided to keep FiO2 at 
1.0 during all the experi-
ment and in all the groups, 
even after ECMO connec-
tion, to avoid the potential 
influence of applying dif-
ferent inspired oxygen 
concentrations on gas 
exchange and lung injury. 
Although this may deviate 
from clinical practice and 
certainly is not an ideal 
setting to protect the 
Table 3. Biochemistry data
Variable SHAM ALI ALI + ECMO
Creatinine (mg·dL-1)   
    Baseline 1.18 [1.17, 1.97] 0.81 [0.73, 0.88]* 1.03 [0.90, 1.04]
    T0 1.05 [0.79, 1.09] 0.91 [0.76, 1.06] 1.03 [0.78, 1.13]
    T12 1.17 [1.13, 1.53]# 1.16 [0.93, 1.39] 1.33 [1.17, 2.37]
    T24 1.33 [0.84, 2.48]# 1.15 [0.99, 1.31] 1.66 [1.24, 2.38]
BUN (mg·dL-1)   
    Baseline 8 [7, 25] 11 [9, 12] 8 [8, 9]
    T0 9 [8, 12] 9 [7, 11] 8 [7, 9]
    T12 23 [16, 25]# 13 [9, 17] 18 [15, 20]
    T24 23 [15, 36]# 12 [9, 15] 21 [17, 29]
SGOT (U·L-1)   
    Baseline 54 [45, 132] 25 [21, 29] 21 [15, 34]
    T0 66 [54, 69] 122 [91, 152] 30 [16, 68]
    T12 88 [58, 141]# 154 [141, 166] 73 [56, 142]
    T24 99 [61, 139]# 266 [162, 370] 117 [85, 200]
Bilirubin (mg·dL-1)   
    Baseline 0.15 [0.15, 0.15] 0.16 [0.15, 0.16] 0.15 [0.15, 0.15]
    T0 0.15 [0.14, 0.16] 0.17[0.15, 0.18] 0.15 [0.15, 0.15]
    T12 0.15 [0.13, 0.15] 0.15 [0.15, 0.15] 0.15 [0.15, 0.17]
    T24 0.15 [0.13, 0.15] 0.14 [0.12, 0.15] 0.15 [0.15, 0.15]
Urea (g·L-1)   
    Baseline 0.17 [0.15, 0.53] 0.21 [0.19, 0.23] 0.17 [0.17, 0.19]
    T0 0.19 [0.17, 0.24] 0.19 [0.15, 0.23] 0.17 [0.15, 0.19]
    T12 0.49 [0.34, 0.54]# 0.28 [0.19, 0.36] 0.37 [0.31, 0.42]
    T24 0.49 [0.28, 0.57]# 0.75 [0.19, 1.31] 0.45 [0.37, 0.61]
pH   
    Baseline 7.53 [7.43, 7.60] 7.48 [7.39, 7.49]# 7.52 [7.42, 7.58]
    T0 7.51 [7.45, 7.58] 7.31 [7.27, 7.37]* 7.42 [7.34, 7.49]
    T12 7.37 [7.33, 7.43]# 7.43 [7.37, 7.49] 7.49 [7.43, 7.50]
    T24 7.43 [7.36, 7.48] 7.49 [7.48, 7.50] 7.45 [7.40, 7.45]
HCO3- (mEq·L-1)   
    Baseline 30.3 [27.8, 33.1] 33.2 [32.3, 35.9] 30.6 [29.6, 34.2]#
    T0 29.5 [28.5, 30.9] 26.8 [23.3, 29.9] 24.8 [20.5, 26.6]*
    T12 25.5 [23.8, 89.9] 34.0 [29.9, 38.0] 24.0 [20.9, 26.1]
    T24 23.7 [20.4, 29.1]# 36.6 [33.2, 40.0] 23.0 [20.2, 25.3]
BE (mEq·L-1)   
    Baseline 8.0 [3.5, 11.5] 10 [8.0, 12] 8.0 [6.0, 12]#
    T0 6.5 [4.5, 8.0] 2.0 [0.0, 8.3] 2.0 [0.0, 6.0] 
    T12 2.0 [1.5, 3.5]# 10 [7.0, 13] 2.0 [-2.0, 3.0]
    T24 3.5 [2.8, 6.5] 13.5 [10, 17] 2.0 [-3.0, 2.0]£
Lactate (mmol·L-1)   
    Baseline 1.6 [1.2, 2.0] 1.4 [1.0, 1.5] 1.5 [1.1, 1.8]#
    T0 1.6 [1.2, 2.3] 2.1 [1.8, 2.8] 3.2 [2.9, 4.5]*
    T12 2.3 [1.7, 4.3] 0.9 [0.8, 1.1] 1.5 [1.4, 2.4]#
    T24 1.5 [0.9, 1.9] 1.3 [1.3, 1.4] 1.2 [1.0, 1.9]#
All results show median [percentile 25, 75] except for ALI group at T12, T24 (median 
[range]). #p < 0.05 compared to T0; *p < 0.05 compared to SHAM; £p < 0.05 compared 
to ALI. BUN, blood urea nitrogen; SGOT, Serum glutamic oxaloacetic transaminase; BE, 
base excess.
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lungs, we thought for the purpose of research 
validity it was important to minimize the poten-
tial covariates.
The major strengths of our model are first, its 
severity, which is important concerning poten-
tial translations to patients with severe respira-
tory failure treated with ECMO. Animals subject-
ed to ALI without ECMO developed severe 
hypoxemia and most of them died before com-
pleting the study period. A second attribute is 
hemodynamic stability, which otherwise could 
preclude using vvECMO. Although we had to 
use moderate doses of Noradrenaline after 
starting ECMO, most animals regained stability. 
A third strength of our model is the use of a 
single BCDL catheter. Cannulation could be 
performed without advanced imaging, which 
frequently is not available in most research 
labs. In addition, we could avoid using the fem-
oral veins, in which due to their deep location, it 
is cumbersome to place large cannulas in large 
animals [10, 22]. Fourth, histologic findings in 
the injured lungs indicate diffuse alveolar dam-
age, as expected in ARDS, which is one of the 
main indications for vvECMO in adults. Finally, 
with the ECMO configuration applied we 
obtained minimal recirculation and a relatively 
high extracorporeal blood flow (> 60 ml·kg-
1·min-1), which allows full extracorporeal lung 
support. This is important to explore more 
extreme forms of lung protection as near-
apneic ventilation.
However, the model also has limitations. It is 
rather expensive, highly demanding and labor-
intensive, therefore requiring a large research 
team. Experimental preparation takes 5 to 6 
hours. Changing repeatedly between supine 
and prone position during induction of lung inju-
ry is laborious. Insertion of a 23 F cannula in 
the external jugular vein is challenging and 
requires dissecting the vein very distally 
towards the sternal notch, where it has a larger 
diameter. Once vvECMO is started measure-
ments of cardiac output by thermodilution are 
no longer reliable due to indicator loss into the 
extracorporeal circulation. In addition, connec-
tion to ECMO while the animals are hypoxemic 
and hypercapnic is followed by a short period of 
hemodynamic instability, which requires vaso-
pressor support. Almost all animals regained 
stability with moderate vasopressor support 
but one of them developed progressive hypo-
tension and finally died early during the model. 
However, this is a price worth to pay in order to 
have a clinically relevant scenario.
Conclusions
The porcine model of ALI induced by repeated 
saline lavage, followed by injurious ventilation, 
exhibits severe hypoxemia that is refractory to 
conventional mechanical ventilation, and has a 
high lethality, accurately resembling severe 
ARDS in humans. The present model can be 
successfully rescued by vvECMO, and support-
ed for 24 hours, providing an adequate model 
for translational research in extracorporeal 
lung support. 
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Supplementary Figure 1. Pilot experiments using near-apneic ventilation. PaO2, PaCO2 (left axis) and minute ventila-
tion (right axis) along the 24-hour study period, corresponding to two pilot animal experiments performed using the 
same model, but applying a near-apneic ventilation strategy (mean and SEM).
